Cavapro 300 mg (Tablet)

Unit Price: ৳ 24.00 (1 x 10: ৳ 240.00)
Strip Price: ৳ 240.00

Medicine Details

Title

  • Irbesartan Tablet

Category

  • Medicine
  • Hypertension Medication
  • Antihypertensive Drug

Description

  • Treatment of essential hypertension
  • Treatment of renal disease in patients with hypertension and type 2 diabetes mellitus
  • Angiotensin II receptor antagonist
  • Pharmacological effects on vasoconstriction and aldosterone secretion
  • Dosage recommendations for adults, elderly, pediatric patients
  • Interactions with diuretics, potassium supplements, lithium, NSAIDs
  • Contraindications with aliskiren, pregnancy
  • Possible side effects like diarrhea, fatigue, dizziness, hyperkalemia
  • Guidelines for use in pregnancy and lactation
  • Precautions for patients with renal artery stenosis, renal impairment, aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy, and lactation
  • Special considerations for patients with renal impairment, hepatic impairment, and primary aldosteronism
  • Information on overdose effects and storage conditions

Dimensions

    Color Options

      Functions

      • Treatment of hypertension
      • Renal disease management

      Materials

        Technical Specifications

          Design Elements

            Usability Features

              Dosage Recommendations

              • Initial and maintenance dose of Irbesartan 150 mg once daily for adults
              • Consideration of a lower starting dose for elderly and pediatric patients
              • Titration up to Irbesartan 300 mg once daily for hypertensive type 2 diabetic patients

              Interactions

              • Effect of prior treatment with high dose diuretics on initiating therapy with Irbesartan
              • Concomitant use of potassium-sparing diuretics, potassium supplements, and drugs that may increase serum potassium levels
              • Possible reversible increases in serum lithium concentrations and toxicity with concomitant administration of lithium
              • Attenuation of the antihypertensive effect when administered simultaneously with non-steroidal anti-inflammatory drugs
              • Pharmacokinetic interactions with hydrochlorothiazide, warfarin, rifampicin, and digoxin

              Contraindications

              • Concomitant use with aliskiren in patients with diabetes and renal impairment (GFR <60 ml/min)
              • Pregnancy

              Possible Side Effects

              • Diarrhoea
              • Fatigue
              • Dizziness
              • Hyperkalaemia
              • Elevated serum creatinine
              • Orthostatic hypotension
              • Nausea
              • Vomiting
              • Musculoskeletal pain
              • Thrombocytopaenia

              Guidelines for Pregnancy & Lactation

              • Contraindicated in the second and third trimesters of pregnancy
              • Precautionary measures during the first trimester of pregnancy
              • Contraindicated during lactation

              Precautions and Warnings

              • Considerations for patients with unilateral or bilateral renal artery stenosis, intravascular volume depletion, aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy
              • Special population considerations for renal impairment, hepatic impairment, hypertensive patients with type 2 diabetes and renal disease, hyperkalaemia, aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy, primary aldosteronism
              • General precautions for patients dependent on the renin-angiotensin-aldosterone system

              Special Population Uses

              • No dosage adjustment necessary in patients with impaired renal function
              • Consideration of a lower starting dose for patients undergoing haemodialysis
              • Consideration of a lower starting dose for patients with mild to moderate hepatic impairment
              • Effects of Irbesartan on renal and cardiovascular events in hypertensive patients with type 2 diabetes and renal disease
              • Risk of hyperkalaemia in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure in patients at risk

              Dosage Overdose Effects

              • Experience with exposure to doses of up to 900 mg/day for 8 weeks revealed no toxicity
              • Expected manifestations of overdosage include hypotension, tachycardia, and bradycardia
              • No specific information available on the treatment of overdosage with Irbesartan

              Therapeutic Class

              • Angiotensin-ll receptor blocker

              Storage Conditions

              • Store in a cool and dry place
              • Protected from light

              Related Brands